Steven Frank

Insider Reports History

Location
Germantown, MD
Signature
/s/ Alane P. Barnes, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steven Frank:

Company Role Class Num Shares Value Price $ Report Date Ownership
PRECIGEN, INC. Director Common Stock 1,140,307 $1,984,134 $1.74 14 Mar 2025 Direct
BIOCRYST PHARMACEUTICALS INC Director Common Stock 17,618 $126,497 $7.18 28 Nov 2025 Direct
PRECIGEN, INC. Director Restricted Stock Units 0 $0 $1.74 14 Mar 2025 Direct
PRECIGEN, INC. Director Option to Purchase Common Stock (Right to Buy) 83,517 13 Mar 2025 Direct
BIOCRYST PHARMACEUTICALS INC Director Automatic Stock Option Grant 27,181 12 Jun 2025 Direct

Insider Reports Filed by Steven Frank

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BCRX BIOCRYST PHARMACEUTICALS INC 28 Nov 2025 1 +$11,244 4 Director 02 Dec 2025, 16:10
BCRX BIOCRYST PHARMACEUTICALS INC 29 Aug 2025 1 +$11,243 4 Director 03 Sep 2025, 16:07
BCRX BIOCRYST PHARMACEUTICALS INC 12 Jun 2025 2 $0 4 Director 16 Jun 2025, 16:18
BCRX BIOCRYST PHARMACEUTICALS INC 30 May 2025 1 +$3,580 4 Director 03 Jun 2025, 16:05
BCRX BIOCRYST PHARMACEUTICALS INC 02 May 2025 2 $0 4 Director 06 May 2025, 16:31
BCRX BIOCRYST PHARMACEUTICALS INC 02 May 2025 0 $0 3 Director 06 May 2025, 16:18
PGEN PRECIGEN, INC. 13 Mar 2025 5 +$49,999 4 Director 17 Mar 2025, 18:28
PGEN PRECIGEN, INC. 14 Mar 2024 3 +$50,000 4 Director 18 Mar 2024, 18:09
PGEN PRECIGEN, INC. 09 Mar 2024 2 $0 4 Director 12 Mar 2024, 19:55
PGEN PRECIGEN, INC. 14 Aug 2023 1 +$688,000 4 Director 15 Aug 2023, 16:18
PGEN PRECIGEN, INC. 09 Mar 2023 3 +$50,000 4 Director 13 Mar 2023, 17:12
PGEN PRECIGEN, INC. 22 Feb 2023 2 $0 4 Director 24 Feb 2023, 19:10
PGEN PRECIGEN, INC. 25 Mar 2022 2 $0 4 Director 29 Mar 2022, 17:08
PGEN PRECIGEN, INC. 22 Feb 2022 3 +$49,999 4 Director 24 Feb 2022, 16:45